|
Volumn 66, Issue 10, 2011, Pages 2438-2440
|
Pharmacokinetics of oral voriconazole in patients with cystic fibrosis
|
Author keywords
Allergic bronchopulmonary aspergillosis; Antifungal; Aspergillus fumigatus
|
Indexed keywords
VORICONAZOLE;
ADULT;
ANTIBIOTIC THERAPY;
AREA UNDER THE CURVE;
CLINICAL ARTICLE;
CYSTIC FIBROSIS;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG DISTRIBUTION;
DRUG DOSE REDUCTION;
DRUG ELIMINATION;
DRUG HALF LIFE;
FEMALE;
FORCED EXPIRATORY VOLUME;
FORCED VITAL CAPACITY;
HUMAN;
LETTER;
LIQUID CHROMATOGRAPHY;
LIVER FUNCTION TEST;
MALE;
MAXIMUM PLASMA CONCENTRATION;
OPEN STUDY;
PANCREAS INSUFFICIENCY;
PHASE 4 CLINICAL TRIAL;
TANDEM MASS SPECTROMETRY;
TIME TO MAXIMUM PLASMA CONCENTRATION;
UNSPECIFIED SIDE EFFECT;
VISUAL DISORDER;
ADMINISTRATION, ORAL;
ADULT;
ANTIFUNGAL AGENTS;
ASPERGILLOSIS;
ASPERGILLUS FUMIGATUS;
CYSTIC FIBROSIS;
FEMALE;
HUMANS;
MALE;
PYRIMIDINES;
TRIAZOLES;
|
EID: 80052901769
PISSN: 03057453
EISSN: 14602091
Source Type: Journal
DOI: 10.1093/jac/dkr300 Document Type: Letter |
Times cited : (8)
|
References (5)
|